You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 23, 2024

CLINICAL TRIALS PROFILE FOR RIDAURA

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for RIDAURA

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT01419691 ↗	Phase I and II Study of Auranofin in Chronic Lymphocytic Leukemia (CLL)	Completed	Kansas Bioscience Authority	Phase 2	2011-09-01	The purpose of this study is to evaluate the safety and effectiveness of auranofin to treat patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or prolymphocytic lymphoma (PLL).
NCT01419691 ↗	Phase I and II Study of Auranofin in Chronic Lymphocytic Leukemia (CLL)	Completed	The Leukemia and Lymphoma Society	Phase 2	2011-09-01	The purpose of this study is to evaluate the safety and effectiveness of auranofin to treat patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or prolymphocytic lymphoma (PLL).
NCT01419691 ↗	Phase I and II Study of Auranofin in Chronic Lymphocytic Leukemia (CLL)	Completed	Therapeutics for Rare and Neglected Diseases (TRND)	Phase 2	2011-09-01	The purpose of this study is to evaluate the safety and effectiveness of auranofin to treat patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or prolymphocytic lymphoma (PLL).
NCT01419691 ↗	Phase I and II Study of Auranofin in Chronic Lymphocytic Leukemia (CLL)	Completed	University of Kansas Medical Center	Phase 2	2011-09-01	The purpose of this study is to evaluate the safety and effectiveness of auranofin to treat patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or prolymphocytic lymphoma (PLL).
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for RIDAURA

Condition Name

Chart
Table

Condition Name for RIDAURA
Intervention	Trials
Unspecified Adult Solid Tumor, Protocol Specific	1
Recurrent Non-Small Cell Lung Carcinoma	1
Recurrent Ovarian Carcinoma	1
Chronic Lymphocytic Leukemia (CLL)	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for RIDAURA
Intervention	Trials
Lung Neoplasms	2
Carcinoma, Non-Small-Cell Lung	2
Ovarian Neoplasms	2
Adenocarcinoma of Lung	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for RIDAURA

Trials by Country

Map
Table

Trials by Country for RIDAURA
Location	Trials
United States	8
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for RIDAURA
Location	Trials
Minnesota	3
Florida	3
Arizona	1
Kansas	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for RIDAURA

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for RIDAURA
Clinical Trial Phase	Trials
Phase 2	3
Phase 1/Phase 2	2
Phase 1	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for RIDAURA
Clinical Trial Phase	Trials
Completed	3
Withdrawn	2
Active, not recruiting	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for RIDAURA

Sponsor Name

Chart
Table

Sponsor Name for RIDAURA
Sponsor	Trials
Mayo Clinic	5
National Cancer Institute (NCI)	4
The Leukemia and Lymphoma Society	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for RIDAURA
Sponsor	Trials
Other	10
NIH	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.